Higher Drug Prices from Anticompetitive Conduct: Three Case Studies
{{output}}
U.S. consumers pay high drug prices. Brand-name drug companies claim that these prices are justified by pathbreaking research and development. But, sometimes the prices result from anticompetitive conduct. This article offers three case studies of how such beh... ...
